Nervgen Pharma Corp

Small-Cap Stocks Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$3.96

+0.04 (+1.02%)

As of Mar 23, 10:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +215.4% upside

Low Target $8.17

Average Target $12.49

High Target $18.41

Current Price $3.96

Current
$3.96

Target
$12.49

$8.17 $12.49 avg $18.41

Scenario Analysis

Bear Case

$8.17

106.3%

Low target

Base Case

$12.49

+215.4%

Avg target

Bull Case

$18.41

+364.9%

High target

Risk/Reward

3.4x

Highly favorable

Price in Context

52-Week High

$8.49

-53.4% from high

52-Week Low

$2.57

+54.1% from low

Target vs 52W High

$12.49

+47.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%